AIST Develops Novel Culture Media Analysis Technology Using Multifluorescent Polymers and AI, Revolutionizing Biomanufacturing Quality Control

AFPBB News Japan

Overview

Japan’s National Institute of Advanced Industrial Science and Technology (AIST) has developed a novel analytical technology to assess the quality of cell culture media and supplements, critical for biomanufacturing. This system employs a sensor with multiple fluorescent polymers to detect the overall characteristics of media as unique fluorescent patterns, which machine learning then uses to identify subtle differences and changes. Unlike conventional component-by-component analysis, this innovation simplifies pre-culture quality checks, prevents costly culture failures, and enhances overall biomanufacturing product quality. The research team from the Health and Medical Engineering Research Institute pioneered this advancement.

In Depth

Background and Challenges in Cell Culture Media Quality Assessment

Cell and microbial culture forms the foundational technology for modern biomanufacturing industries, including biopharmaceuticals, regenerative medicine products, and cultivated meat. The success of these endeavors is highly dependent on the quality of the culture media and supplements used. However, culture media, composed of diverse ingredients, can exhibit subtle variations in quality between batches or due to storage conditions. Traditional quality assessment methods necessitate detailed, component-by-component analysis, which is laborious, time-consuming, and often fails to capture holistic changes in the media’s overall characteristics.

Consequently, there has been a strong demand for new technologies that can rapidly and accurately evaluate media quality before cultivation, thereby mitigating the risk of culture failures.

AIST’s Novel Analytical Technology Using Multifluorescent Polymers

To address these challenges, a research team at Japan’s National Institute of Advanced Industrial Science and Technology (AIST) has developed a groundbreaking analytical technology for evaluating the quality of cell culture media and supplements.

• Multifluorescent Polymer Sensor: At the core of this technology is a sensor that combines multiple fluorescent polymers, each possessing distinct fluorescent properties. These polymers interact with various components within the culture medium, emitting unique fluorescent patterns.
• Holistic Characteristic Detection: Instead of isolating and analyzing individual components, the sensor detects a comprehensive “fingerprint” of the entire culture medium’s fluorescent pattern. This enables a holistic capture of subtle chemical compositions and structural changes that are often undetectable by conventional methods.
• Machine Learning for Identification: The complex fluorescent patterns detected are then analyzed using machine learning algorithms. Machine learning is trained to identify minute differences in fluorescent patterns that distinguish between media of varying quality, automatically classifying and assessing the media’s state. This eliminates human variability in judgment, ensuring objective and highly reproducible evaluations.

This research was conducted by Shunsuke Tomita, Kumi Morikawa, Nao Kojima, Sayaka Ishihara, Ryoji Kurita from the Health and Medical Engineering Research Institute, and Hiroyuki Kusada and Hideki Tamaki from the Biomanufacturing Research Center.

Industry Impact and Future Outlook

This novel culture media analysis technology is expected to have widespread implications for the biomanufacturing industry:

• Simplified and Expedited Quality Control: By replacing complex, component-specific analyses with rapid, straightforward fluorescent pattern detection and machine learning-based evaluation, the process of media incoming inspection and pre-culture quality checks will be significantly streamlined.
• Reduced Risk of Culture Failure: The ability to accurately detect abnormalities in media quality before cultivation can prevent costly issues such such as culture failures or compromised product quality. This contributes to manufacturing process stability and cost reduction.
• Enhanced Overall Biomanufacturing Quality: Stable supply and utilization of high-quality media ensure consistency in the final bioproducts, contributing to improved safety and efficacy of regenerative medicine and biopharmaceuticals.
• Expanded Technological Applications: Beyond cell culture media, this technology shows promise for quality evaluation of various biological samples and environmental samples, and even for real-time monitoring in specific bioprocesses.

AIST’s innovative media analysis technology is poised to become a critical foundational technology for Japan’s biomanufacturing sector, enhancing its international competitiveness. It exemplifies how the convergence of advanced analytical science and AI can open new avenues for solving complex manufacturing challenges in the life sciences, providing more reliable and efficient bioproduction worldwide.